Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03061981 · ClinicalTrials.gov registry record · Phase 1
A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects
A Phase 1 study, sponsored by Dong-A ST Co..
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT03061981 is a Phase 1 study that has completed, run by Dong-A ST Co.. The registered enrollment target is 60 participants.
The verdict
NCT03061981, a Phase 1 study, has completed, sponsored by Dong-A ST Co..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a randomized, double blind, placebo controlled, single ascending dose study to assess the safety, tolerability, PK, PD and IE with metformin following a single oral dose of DA-1241 in healthy male subjects.
Interventions
- DRUG Placebo
- DRUG Metformin
- DRUG DA-1241
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-03-29 |
| Est. Completion | 2017-10-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03061981
The ClinicalTrials.gov registry entry for NCT03061981 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dong-A ST Co., which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03061981 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03061981 about?
NCT03061981 is a clinical study titled "A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects". This is a randomized, double blind, placebo controlled, single ascending dose study to assess the safety, tolerability, PK, PD and IE with metformin following a single oral dose of DA-1241 in healthy male subjects.
What is the current status of trial NCT03061981?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2017-03-29. Estimated completion is 2017-10-11.
What interventions are being tested in trial NCT03061981?
The interventions under investigation include: Placebo (DRUG), Metformin (DRUG), DA-1241 (DRUG).
Who is sponsoring clinical trial NCT03061981?
This trial is sponsored by Dong-A ST Co., which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.